February 9, 2026

Prestige Consumer Healthcare (PBH) Stock Analysis: Is a 17.34% Potential Upside Worth the Investment?

Investors looking for opportunities in the healthcare sector might find Prestige Consumer Healthcare Inc. (NYSE: PBH) an intriguing prospect, especially given the company’s potential upside of 17.34%. Specializing in over-the-counter..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Navigating its Growth Trajectory with 3.39% Potential Upside

Akero Therapeutics, Inc. (NASDAQ: AKRO), a burgeoning entity in the biotechnology sector, has caught the attention of investors with its focus on developing groundbreaking treatments for serious metabolic diseases. Headquartered..

RadNet, Inc. (RDNT) Stock Analysis: Unpacking a 32% Upside Potential Amid Healthcare Expansion

RadNet, Inc. (NASDAQ: RDNT), a pivotal player in the Healthcare sector and specialized in the Diagnostics & Research industry, is capturing investor attention with its remarkable growth potential. With a..

BrightSpring Health Services (BTSG) Rating Update: 16 Buy Ratings Signal Strong Growth Potential

BrightSpring Health Services, Inc. (BTSG) stands out in the healthcare sector, delivering robust growth and attracting significant investor interest. With a market capitalization of $7.16 billion, this U.S.-based company is..

Genmab A/S (GMAB) Stock Analysis: Biotechnology Giant Poised for 22.75% Upside with Strong Buy Ratings

Investors eyeing the healthcare sector often turn their attention to Genmab A/S (NASDAQ: GMAB), a leading biotechnology company headquartered in Copenhagen, Denmark. With a robust market capitalization of $19.03 billion,..

Revvity, Inc. (RVTY) Stock Analysis: A Potential 17.69% Upside in the Healthcare Diagnostics Sector

For investors with an interest in the healthcare sector, Revvity, Inc. (NYSE: RVTY) presents a compelling opportunity. With a market capitalization of $11.79 billion, this U.S.-based company operates in the..

BioNTech SE (BNTX) Stock Analysis: A 31.79% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), a leading player in the biotechnology sector, has been making waves in the healthcare industry with its cutting-edge immunotherapies targeting cancer and infectious diseases. Headquartered in..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Exploring a 53.95% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves in the biotechnology sector with its innovative approach to treating B-cell mediated diseases. As a commercial-stage biopharmaceutical company, TG Therapeutics is not..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A 169.50% Potential Upside Amid Clinical Advancements

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is generating considerable buzz in the healthcare sector with its promising stock potential. As a clinical-stage biopharmaceutical company, Soleno is dedicated to developing novel treatments..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating the Healthcare Sector with a 28.90% Upside Potential

Oscar Health, Inc. (NYSE: OSCR) is carving out its niche in the competitive healthcare sector. As a technology-driven healthcare company, Oscar Health offers an array of services, including health plans..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating Growth with a 2.72% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) continues to be a significant player in the global healthcare sector, primarily within the drug manufacturing industry for specialty and generic products. Headquartered in..

Encompass Health Corporation (EHC) Stock Analysis: Uncovering a 35% Upside Potential

Encompass Health Corporation (NYSE: EHC) is a prominent player in the healthcare sector, specializing in post-acute care services. With a market capitalization of $10.6 billion, this Birmingham, Alabama-based company is..

Fresenius Medical Care AG (FMS) Stock Analysis: Evaluating a 17% Potential Upside in Healthcare

Fresenius Medical Care AG (NYSE: FMS), a prominent player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling narrative for investors with a 17.15% potential..

Alkermes plc (ALKS) Stock Analysis: Why Investors Should Consider the 25.5% Upside Potential

Alkermes plc (NASDAQ: ALKS) is capturing the attention of investors with its noteworthy potential for growth. As a prominent player in the healthcare sector, specifically in the specialty and generic..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

For investors seeking opportunities within the healthcare sector, Avidity Biosciences, Inc. (NASDAQ: RNA) presents a fascinating case. This biopharmaceutical company, headquartered in San Diego, California, specializes in RNA therapeutics, specifically..

Masimo Corporation (MASI) Stock Analysis: Analyzing the 32% Potential Upside

Masimo Corporation (MASI), a leader in the healthcare sector specializing in innovative medical devices, is drawing significant attention from investors due to a potential upside of 32.05%. With a current..

Teleflex Incorporated (TFX) Investor Outlook: Analyzing a 19.21% Potential Upside for This Medical Device Innovator

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $4.79 billion, Teleflex is..

Tempus AI, Inc. (TEM) Stock Analysis: Healthcare Innovator with 60% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, has captured investor attention with its innovative approach to health information services. With a market capitalization of..

Insmed Incorporated (INSM) Stock Analysis: A 43.57% Upside Potential in Biotechnology

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is currently attracting attention from investors with its impressive market cap of $31.96 billion. Specializing in therapies for serious..

Search

Funds

February 9, 2026

Search

Funds

February 9, 2026

FTSE 100

Funds